https://medicaldialogues.in/news/industry/pharma/astrazeneca-voydeya-approved-in-eu-as-add-on-treatment-to-ravulizumab-or-eculizumab-for-adults-with-pnh-who-have-residual-haemolytic-anaemia-127720